Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trialAmy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, David A Cairns, Anna Hockaday, Jennifer Bird, Stella Bowcock, Martin Kaiser, Ruth de Tute, Neil Rabin, Kevin Boyd, John Jones, Christopher Parrish, Hayley Gardner, David MeadsSee the full list of authors
2 June 2022
Changes in perioperative red cell transfusion practice over time in patients undergoing surgery for upper gastrointestinal and liver cancer: a retrospective cohort study at a single tertiary centreMei Yi Yee, Ewen Harrison, Riinu Pius, Michael Gillies
9 May 2022
Time to detection of anaemia and its predictors among women of reproductive-age living with HIV/AIDS initiating ART at public hospitals, Southwest Ethiopia: a multicentre retrospective follow-up studyAlemayehu Sayih Belay, Yalemtsehay Dagnaw Genie, Belete Fenta Kebede, Aychew Kassie, Abebaw Molla
21 April 2022
Association between PCV13 pneumococcal vaccination and risk of hospital admissions due to pneumonia or sepsis among patients with haematological malignancies: a single-centre retrospective cohort study in IsraelRegina Draliuk, Efrat Shadmi, Meir Preis, Efrat Dagan
15 April 2022
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, Suresh Kumar, Ekta Gupta, Pratibha kale, Vandana Saluja, Sherin S Thomas, Nirupama Trehanpati, Chhagan Bihari, Reshu Agarwal, Praveen Bharti, Prabha Shankar, Javid Hussain, Karan ChhabraSee the full list of authors
6 April 2022
Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancersDorothy McCaughan, Eve Roman, Alexandra Smith, Russell Patmore, Debra Howell
29 March 2022
Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of GenevaWedali E Jimaja, Jerome Stirnemann, Pierre Fontana, Katherine S Blondon
15 March 2022
AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitorsTadashi Matsushita, Nobuaki Suzuki, Azusa Nagao, Chiai Nagae, Haruko Yamaguchi-Suita, Yui Kyogoku, Akiko Ioka, Keiji Nogami
14 March 2022
Ferritin-guided iron supplementation in whole blood donors: optimal dosage, donor response, return and efficacy (FORTE)—a randomised controlled trial protocolJan Karregat, Maike G Sweegers, Franke A Quee, Henriëtte H Weekamp, Dorine W Swinkels, Vĕra M J Novotny, Hans L Zaaijer, Katja van den Hurk
9 March 2022
Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trialTobias Menne, Daniel Slade, Joshua Savage, Sarah Johnson, Julie Irving, Pamela Kearns, Ruth Plummer, Geoff Shenton, Gareth J Veal, Britta Vormoor, Josef Vormoor, Lucinda Billingham
4 March 2022
